Gene therapy: A promising candidate for cystic fibrosis treatmentNovember 16, 2015
An improved gene therapy treatment can cure mice with cystic fibrosis (CF). Cell cultures from CF patients, too, respond well to the treatment. Those are the encouraging results of a study presented by the Laboratory for Molecular Virology and Gene Therapy at KU Leuven, Belgium.
Cystic fibrosis or mucoviscidosis is a genetic disorder that makes the mucus in the body thick and sticky, which in turn causes clogging in, for instance, the airways and the gastrointestinal tract. The symptoms can be treated, but there is no cure for the disorder.
Cystic fibrosis is caused by mutations in the CFTR gene. This gene contains the production code for a protein that functions as a channel through which chloride ions and water flow out of cells. In the cells of CF patients, these chloride channels are dysfunctional or even absent, so that thick mucus starts building up.
"A few years ago, a new drug was launched that can repair dysfunctional chloride channels", Professor Zeger Debyser explains. "Unfortunately, this medicine only works in a minority of CF patients. As for the impact of gene therapy, previous studies suggested that the treatment is safe, but largely ineffective for cystic fibrosis patients. However, as gene therapy has recently proven successful for disorders such as haemophilia and congenital blindness, we wanted to re-examine its potential for cystic fibrosis".
That is why lead authors Dragana Vidovi and Marianne Carlon examined an improved gene therapy treatment based on inserting the genetic material for chloride channels -- coded by the CFTR gene -- into the genome of a recombinant AAV viral vector , which is derived from the relatively innocent AAV virus. The researchers then used this vector to 'smuggle' a healthy copy of the CFTR gene into the affected cells.
Both in mice with cystic fibrosis and in gut cell cultures from CF patients, this approach yielded positive results. "We administered the rAAV to the mice via their airways. Most of the CF mice recovered. In the patient-derived cell cultures, chloride and fluid transport were restored".
There is still a long way to go before gene therapy can be used to treat cystic fibrosis patients, Debyser clarifies: "We must not give CF patients false hope. Developing a treatment based on gene therapy will take years of work. For one thing, our study did not involve actual human beings, only mice and patient-derived cell cultures. Furthermore, we still have to examine how long the therapy works. Repeated doses might be necessary. But gene therapy clearly is a promising candidate for further research towards a cure for cystic fibrosis".
This research was conducted in collaboration with the University Hospitals Leuven and the universities of Paris, Utrecht, and Rotterdam.
Related Cystic Fibrosis Current Events and Cystic Fibrosis News Articles
Therapeutically robust correction, in vitro, of the most common cystic fibrosis mutation
In experiments with isolated cystic fibrosis lung cells, University of Alabama at Birmingham researchers and colleagues from two other institutions have partially restored the lost function of those cells.
'Phage' fishing yields new weapon against antibiotic resistance
Yale researchers were fishing for a new weapon against antibiotic resistance and found one floating in a Connecticut pond, they report May 26, 2016 in the journal Scientific Reports.
Steps that lead to genes being switched on revealed in atomic simulation
Proteins are essential for processes that sustain life. They are created in cells through a process called gene expression, which uses instructions from stretches of DNA called genes to build proteins.
Queen's scientists develop new treatment to prolong life of those with cystic fibrosis
Scientists at Queen's University Belfast have discovered a new molecule which has the potential to prolong the life of individuals with cystic fibrosis (CF).
New electronic stethoscope and computer program diagnose lung conditions
The classic stethoscope has entered the digital age. Medical researchers have created a computer program that connects to an electronic stethoscope to classify lung sounds into five common diagnostic categories.
UA College of Pharmacy faculty member develops inhalers to treat lung diseases
Heidi M. Mansour, PhD, assistant professor in the University of Arizona College of Pharmacy, is working to develop advanced dry powder inhalers to treat and prevent pulmonary diseases.
New method prevents premature halt in protein synthesis in certain genetic illnesses
Improperly formed proteins can cause a host of serious illnesses, from muscular dystrophy to cystic fibrosis.
TSRI scientists find protein 'talks' to wrong partners in cystic fibrosis
Scientists at The Scripps Research Institute (TSRI) have found evidence that a mutant protein responsible for most cases of cystic fibrosis is so busy "talking" to the wrong cellular neighbors that it cannot function normally and is prematurely degraded.
A new target for immuno-oncology therapies
By studying a type of immune cells, a team of researchers at the IRCM led by AndrĂ© Veillette, MD, identified the mechanism of action for a new target for novel immune-oncology treatments.
Chemists turn bacterial molecules into potential drug molecules
Yan-Yeung Luk, associate professor of chemistry, and his research team have published their findings in ChemBioChem (John Wiley & Sons, 2015), explaining how they have created molecules that mimic and dominate toxic ones secreted by bacteria. The implications for the study of biology and pharmacology are said to be enormous.
More Cystic Fibrosis Current Events and Cystic Fibrosis News Articles